Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-04-18 @ 7:52 AM
Study NCT ID:
NCT01853618
Status:
COMPLETED
Last Update Posted:
2019-12-10
First Post:
2013-05-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-02
First Submit QC Date:
None
Study First Post Date:
2013-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-10-08
Results First Submit QC Date:
None
Results First Post Date:
2019-12-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-21
Last Update Post Date:
2019-12-10
Last Update Post Date Type:
ACTUAL